World of DTC Marketing

JANUARY 4, 2021

KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Many organizations have postponed market research due to the pandemic but knowledgeable DTC marketers should be aware of the progressive trends in healthcare.

Marketing 271

Marketing Branding Engineer Doctors 271

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130

Marketing Compliance Doctors Doctor 130

Drug Discovery World

MAY 7, 2024

Dr Nigam will outline the role of software in accelerating the pace of discovery of antibody therapeutics while Dr Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. What you will learn: Where is the opportunity in the mAb market and where is the market heading?

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

Abpro has entered a strategic collaboration with Celltrion for the global development and commercialisation of the former's antibody therapy, a t-cell engager known as ABP 102. The cancer molecule will be developed for treating patients with HER2+ cancer, including gastric, pancreatic and breast cancer.

Antibody 130

Antibody Development Bioinformatics In-Vitro 130

Drug Discovery World

APRIL 8, 2024

Dr Nigam will outline the role of software in accelerating the pace of discovery of antibody therapeutics while Dr Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. What you will learn: Where is the opportunity in the mAb market and where is the market heading?

Antibody 59

Antibody Marketing Gene Therapy Engineer 59

Drug Discovery World

APRIL 22, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. Dr Paola Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. The post Webinar: How can we develop better therapeutic antibodies?

Antibody 52

Antibody Development Gene Therapy Marketing 52

Drug Discovery World

APRIL 29, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. Dr Paola Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. Register for free now to secure your place.

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

XTalks

FEBRUARY 21, 2024

This episode features an interview with Amir Reichman, CEO of Scinai Immunotherapeutics , a biopharma company focused on developing cutting-edge biological treatments within the inflammation and immunology (I&I) sector, with a primary focus on addressing autoimmune and infectious diseases.

Life Science 105

Life Science Development Antibody Vaccination 105

Drug Discovery World

APRIL 15, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. Dr Paola Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. Register for free now to secure your place.

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

Scienmag

DECEMBER 6, 2021

According to a report by Allied Market Research, the global market for ‘smart’ cars—vehicles featuring a range of technologies and connectivity solutions featuring geospatial and remote sensing—has grown dramatically in recent years, and is expected to reach $225.16 billion by 2027.

Engineer 60

Engineer Development Marketing Research 60

Drug Discovery World

APRIL 8, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. Dr Paola Genevini will discuss the generation of recombinant tool antibodies to support cell and gene therapy development. The post Where is the opportunity in the therapeutic antibody market?

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. The firms intend to merge their expertise to provide simplified viral vector gene therapy development, production and testing in Japan.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

Drug Discovery World

MARCH 20, 2024

The proceeds will be used to advance CPTX2309, Capstan’s lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders, and to further develop Capstan’s tLNP pipeline.

In-Vivo 52

In-Vivo Development Engineer Marketing 52

Pharma Marketing Network

OCTOBER 13, 2023

Pharmaceutical marketers are facing a more competitive landscape than ever before, with a variety of new technologies and strategies to keep up with. This article will discuss the current pharma PPC landscape, and offer strategies to maximize ROI in a highly competitive market.

Marketing 52

Marketing Engineer Development Research 52

Pharmaceutical Technology

DECEMBER 19, 2022

With the latest development, Sanofi will licence a NK cell engager programme that acts on B7H3 from the antibody-based NK cell engager therapeutics (ANKET) platform of Innate. On choosing the candidate, the company will oversee the complete development, production and marketing.

Development 264

Development Engineer Clinical Trials Clinical Trials 264

Pharma Marketing Network

JULY 25, 2023

In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. Additionally, establish a realistic budget that you are willing to invest in digital marketing services.

Marketing 98

Marketing Engineer Branding Research 98

Drug Discovery World

JUNE 1, 2023

According to NCBI, most of the ADCs developed so far are for use in the treatment of cancer, but there is plenty of potential for using ADCs to treat other diseases 1. A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2.

Antibody 98

Antibody Marketing Drugs Licensing 98

Roots Analysis

DECEMBER 9, 2021

Even though efforts for development of HER2 targeting therapies have been undertaken by players based all across the globe, majority of the developers are headquartered in North America. Within North America, US has emerged as a prominent region where maximum product developers are located.

Marketing 52

Marketing Development Gene Protein 52

XTalks

JULY 5, 2023

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. The goal of CytoMed is to develop efficient and cost-effective cellular immunotherapy solutions for solid tumors and hematologic cancers.

Life Science 97

Life Science Development Engineer Scientist 97

pharmaphorum

FEBRUARY 9, 2022

But how can we make Customer Engagement effective, and how can we leverage technologies like AI and Marketing Automation to their best potential? The Event – Helping marketers to face Business Challenges. AiDEA Marketing – One conversation, multiple channels! Martina Fiore – Head of Marketing, Trueblue Srl.

Marketing 104

Marketing Life Science Engineer Development 104

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Sales 98

Sales Marketing Branding Production 98

XTalks

JUNE 26, 2023

Content marketing not only builds trust and credibility but also helps in driving brand awareness which attracts potential customers. Life science companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies.

Life Science 98

Life Science Marketing Sales Production 98

Pharma Marketing Network

SEPTEMBER 19, 2023

Digital marketing has revolutionized the way individuals and businesses communicate. In the pharmaceutical industry, digital marketing has become a powerful tool for connecting with customers and building brand loyalty. Digital marketing is also highly customizable, allowing businesses to tailor their campaigns to a specific audience.

Marketing 52

Marketing Branding Engineer Development 52

Pharmaceutical Technology

JUNE 12, 2023

Quell Therapeutics and AstraZeneca have entered a collaboration, exclusive option and licence deal for the development, manufacturing and commercialisation of engineered T-regulator (Treg) cell therapies for autoimmune diseases. AstraZeneca will make an upfront payment to Quell of $85m, mostly in cash.

Engineer 130

Engineer Gene Therapy Clinical Trials Clinical Trials 130

Roots Analysis

MARCH 16, 2022

In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Want additional details on the pipeline?

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

Cloudbyz

MARCH 5, 2024

In the intricate dance of drug discovery and development, two protagonists emerge as the cornerstones of modern medicine: biologics and small molecules. Development and Approval : Small Molecules: The pathway for development and regulatory approval is well-established, with clear guidelines for demonstrating safety and efficacy.

Development 78

Development Drugs Manufacturing Immune Response 78

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 104

Genome Genomics Medicine Development 104

Drug Discovery World

FEBRUARY 6, 2024

From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows, digital technologies are having a significant impact on drug discovery and development.

Marketing 69

Marketing Medicine Genome Genomics 69

Pharmaceutical Technology

JANUARY 4, 2023

Cell-engineering company MaxCyte has signed a strategic platform licence (SPL) with biotechnology company Catamaran Bio to support the chimeric antigen receptor (CAR)-NK cell therapy programmes. These CAR-NK cell therapies combine new functional attributes with the NK cells’ inherent cancer-fighting properties.

Engineer 130

Engineer Gene Therapy Gene Development 130

Pharmaceutical Technology

DECEMBER 8, 2022

Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K.,

Licensing 305

Licensing Licensing Gene Therapy Gene 305

XTalks

JANUARY 17, 2024

Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.

Life Science 115

Life Science Engineer Business Development Manufacturing 115

Roots Analysis

NOVEMBER 30, 2021

Bioassay – A Prerequisite for the Cell and Gene Therapy Development. In fact, from year 2016 to 2020 more than 300 IND filing for cell and gene therapy product have been recorded, indicating that several developers and innovators are more attracted towards the cell and gene therapies.

Bioassay 52

Bioassay Gene Therapy Gene Development 52

Pharmaceutical Technology

JANUARY 27, 2023

Being co-developed and co-marketed by AstraZeneca and Daiichi Sankyo, Enhertu is a particularly engineered HER2-directed antibody-drug conjugate (ADC). It has been developed using the DXd ADC technology from Daiichi Sankyo.

HR 235

HR Engineer Antibody Medicine 235

Pharmaceutical Technology

OCTOBER 20, 2022

Ayala Pharmaceuticals has signed a definitive merger agreement with biotechnology company Advaxis, which discovers, develops and markets immunotherapies. Advaxis’ immunotherapies are based on a technology that leverages engineered Listeria monocytogenes. Stockholders of Ayala will own nearly 62.5%

Engineer 130

Engineer Development Trials Marketing 130

Pharma Marketing Network

OCTOBER 31, 2023

These strategies include creating an engaging website, optimizing for search engines, developing digital marketing campaigns, and leveraging customer data to personalize the user experience. By leveraging online sales, pharmaceutical companies can expand their customer base and reach new markets.

Sales 52

Sales Engineer Regulation Marketing 52

Pharmaceutical Technology

JANUARY 13, 2023

Being co-developed and co-marketed by Daiichi Sankyo along with AstraZeneca , Enhertu is a specifically engineered HER2-directed antibody-drug conjugate (ADC).

HR 321

HR Trials Engineer Clinical Trials 321

Drug Discovery World

AUGUST 14, 2023

Over the past few decades, the incredible progress in personalised medicine has led to the development of life-saving cell and gene therapies (CGT). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4 billion in 2020 to $15.5 billion in 2025 at a rate of 28.7%

Gene Therapy 52

Gene Therapy Marketing Gene DNA 52